| GISSI | Italian Study Group for the Prevention of Myocardial Infarction [Gruppo Italiano per lo Studio della... |
|---|---|
| COA | Canadian Ophthalmological Association; Canadian Orthopaedic Association; certificate of authority; c... |
| CPA | Canadian Physiotherapy Association; Canadian Psychiatric Association; carboxypeptidase A; cardiopulm... |
| AJKD | American Journal of Kidney Diseases |
| JOC | Journal of Oncologic Clinical(?) |
| JAMA | Journal of the American Medical Association |
|---|---|
| NEJM | New England Journal of Medicine |
| CCS | Canadian Cardiovascular Society |
| CF | Canadian Forces |
| CNS | Canadian Neurological Scale |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| Italian flap | Flap from a distant area; usually used in reference to a flap from the upper arm to rebuild a nose. (05 Mar 2000) |
| Italian method | Italian method rhinoplasty utilizing a flap from the arm. Synonym: Italian method, Italian operation, tagliacotian operation. (05 Mar 2000) |
| Italian operation | Italian method rhinoplasty utilizing a flap from the arm. Synonym: Italian method, Italian operation, tagliacotian operation. (05 Mar 2000) |
| Italian rhinoplasty | Italian method rhinoplasty utilizing a flap from the arm. Synonym: Italian method, Italian operation, tagliacotian operation. (05 Mar 2000) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
| sampling studies | Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. (12 Dec 1998) |
| prospective studies | Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|